Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ivabradine/metoprolol - Servier

Next Previous
Drug Profile

Ivabradine/metoprolol - Servier

Alternative Names: IMPLICOR; Metoprolol/ivabradine

Latest Information Update: 25 Jan 2019

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Servier
  • Class Antihypertensives; Benzazepines; Bradycardic agents; Class II antiarrhythmics; Heart failure therapies; Heterocyclic bicyclo compounds; Ischaemic heart disorder therapies; Propanolamines; Small molecules
  • Mechanism of Action Beta 1 adrenergic receptor antagonists; Hyperpolarisation activated cation channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Angina pectoris

Most Recent Events

  • 25 Jan 2019 Chemical structure information added
  • 23 Jan 2019 Ivabradine/metoprolol is not yet available in Netherlands, Austria, Belgium, Bulgaria, Croatia, Cyprus, Denmark, Finland, France, Germany, Hungary, Italy, Latvia, Liechtenstein, Lithuania, Malta, Norway, Romania, Slovenia, Sweden and Slovakia (PO)
  • 23 Jan 2019 Launched for Angina pectoris in Estonia, prior January 2019 (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top